SCHEMBL19081847

SCHEMBL19081847

c1cc(-c2ccc3ccccc3c2)cc(-c2c3ccccc3c(-c3ccc4c(c3)oc3c4ccc4c5ccc6ccccc6c5sc43)c3ccccc23)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 13/20 0.39
CYP1B1 Q16678 13/20 0.39
CYP1A2 P05177 12/20 0.36
HSD17B1 P14061 2/20 0.34
HSD17B2 P37059 2/20 0.34
PRKDC P78527 2/20 0.32
CYP3A4 P08684 2/20 0.32
CYP2D6 P10635 2/20 0.32
CYP2C9 P11712 2/20 0.32
CYP2B6 P20813 2/20 0.32
CYP2C19 P33261 2/20 0.32
KDM4E B2RXH2 1/20 0.32
PDE5A O76074 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TP53 P04637 1/20 0.32
ABCB1 P08183 1/20 0.32
MAPT P10636 1/20 0.32
CYP19A1 P11511 1/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081982 0.92 CYP1A1 (0.38) CYP1A1CYP1B1CYP1A2HSD17B1HSD17B2
SCHEMBL19081987 0.88 CYP1A1 (0.36) CYP1A1CYP1B1CYP1A2HSD17B1HSD17B2
SCHEMBL16068009 0.87 CYP1A1 (0.49) CYP1A1CYP1B1CYP1A2HSD17B1HSD17B2
SCHEMBL16067776 0.87 CYP1A1 (0.49) CYP1A1CYP1B1CYP1A2HSD17B1HSD17B2
SCHEMBL19076740 0.87 ALOX5 (0.39) CYP1A1CYP1B1CYP1A2PRKDCCYP2C9
SCHEMBL17932264 0.85 ALOX5 (0.35) CYP1A1CYP1B1CYP1A2HSD17B1HSD17B2
SCHEMBL19081981 0.84 CYP1A1 (0.38) CYP1A1CYP1B1CYP1A2HSD17B1HSD17B2
SCHEMBL24341008 0.84 CYP1A1 (0.43) CYP1A1CYP1B1CYP1A2HSD17B1HSD17B2
SCHEMBL17945081 0.84 ALOX5 (0.41) CYP1A1CYP1B1CYP1A2HSD17B1HSD17B2
SCHEMBL17932113 0.84 ALOX5 (0.41) CYP1A1CYP1B1CYP1A2HSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.